As of 2026-03-17, the Intrinsic Value of Forte Biosciences Inc (FBRX) is -20.65 USD. This FBRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 26.74 USD, the upside of Forte Biosciences Inc is -177.21%.
Based on its market price of 26.74 USD and our intrinsic valuation, Forte Biosciences Inc (FBRX) is overvalued by 177.21%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -20.65 - -20.65 | -20.65 | -177.21% |
| P/E | (89.20) - (94.98) | (94.25) | -452.5% |
| DDM - Stable | (27.87) - (99.58) | (63.72) | -338.3% |
| DDM - Multi | (17.11) - (49.19) | (25.58) | -195.6% |
| Market Cap (mil) | 335.05 |
| Beta | 1.12 |
| Outstanding shares (mil) | 12.53 |
| Enterprise Value (mil) | 241.64 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.05% |
| Cost of Debt | 5.00% |
| WACC | 7.36% |